The TWEAK-Fn14 pathway: A potent regulator of skeletal muscle biology in health and disease

被引：41
|
作者：
Tajrishi, Marjan M. [1 ]
Zheng, Timothy S. [2 ]
Burkly, Linda C. [2 ]
Kumar, Ashok [1 ]
机构：
[1] Univ Louisville, Sch Med, Louisville, KY 40202 USA
[2] Biogen Idec Inc, Dept Immunol, Cambridge, MA 02142 USA
来源：
CYTOKINE & GROWTH FACTOR REVIEWS | 2014年 / 25卷 / 02期
关键词：
Skeletal muscle atrophy; Regeneration; NF-kappa B; Tissue injury; Fibrosis; NF-KAPPA-B; WEAK INDUCER; APOPTOSIS TWEAK; SIGNALING PATHWAYS; MOLECULAR-MECHANISMS; PGC-1; COACTIVATORS; TARGETED ABLATION; MYOBLAST FUSION; TNF-ALPHA; ATROPHY;
D O I：
10.1016/j.cytogfr.2013.12.004
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TNF-like weak inducer of apoptosis (TWEAK), a TNF superfamily ligand, and its bona fide receptor, the TNF receptor superfamily member fibroblast growth factor-inducible 14 (Fn14), represent a pivotal axis for shaping both physiological and pathological tissue responses to acute or chronic injury and disease. In recent years significant advances have been made in delineating the prominent role of TWEAK-Fn14 dyad in regulating skeletal muscle mass and metabolism. Also emerging from the broad study of tissue injury in skeletal muscle and other organs is the role of the TWEAK-Fn14 pathway in promoting fibrosis. This review article highlights recent advancements toward understanding how the TWEAK-Fn14 pathway regulates the response to various skeletal muscle insults and, more broadly, engages multiple mechanisms to drive tissue fibrosis. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：215 / 225
页数：11
相关论文
共 50 条
  • [21] The role of the TWEAK/Fn14 pathway in muscle pathology in SMA
    Meijboom, K. E.
    Hazell, G.
    McFall, E.
    Deguise, M-O.
    Anthony, D.
    Burkly, L. C.
    Kothary, R.
    Wood, M. J. A.
    Bowerman, M.
    [J]. NEUROMUSCULAR DISORDERS, 2017, 27 : S30 - S30
  • [22] EGR1 is a mediator of TWEAK-Fn14 pathway induced prostate cancer bone metastasis
    Ameri, Amir H.
    Yin, Juan Juan Ivy
    Jansen, Keith
    Wang, Simeng
    Snyder, Jessica
    Hynes, Paul
    Kelly, Kathleen
    [J]. CANCER RESEARCH, 2015, 75
  • [23] TWEAK-Fn14 Axis: A Potential Therapeutic Target for Treating Heart Failure
    Unudurthi, Sathyadev
    Thomas, Evelyn
    Patel, Nehal
    Winkle, Alexander
    Gratz, Daniel
    Hund, Thomas
    [J]. CIRCULATION RESEARCH, 2019, 125
  • [24] TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration
    Girgenrath, Mahasweta
    Weng, Shawn
    Kostek, Christine A.
    Browning, Beth
    Wang, Monica
    Brown, Sharron A. N.
    Winkles, Jeffrey A.
    Michaelson, Jennifer S.
    Allaire, Norm
    Schneider, Pascal
    Scott, Martin L.
    Hsu, Yen-ming
    Yagita, Hideo
    Flavell, Richard A.
    Miller, Jeffrey Boone
    Burkly, Linda C.
    Zheng, Timothy S.
    [J]. EMBO JOURNAL, 2006, 25 (24): : 5826 - 5839
  • [25] A Homogeneous HTRF Assay for the Identification of Inhibitors of the TWEAK-Fn14 Protein Interaction
    Benicchi, Tiziana
    Iozzi, Sara
    Svahn, Andreas
    Axelsson, Hanna
    Mori, Elisa
    Bernocco, Simonetta
    Cappelli, Federico
    Caramelli, Chiara
    Fanti, Paola
    Genesio, Eva
    Maccari, Laura
    Markova, Natalia
    Micco, Iolanda
    Porcari, Valentina
    Schultz, Johan
    Fecke, Wolfgang
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (07) : 933 - 945
  • [26] Targeting the TWEAK-Fn14 pathway prevents dysfunction in cardiac calcium handling after acute kidney injury
    Poveda, Jonay
    Gonzalez-Lafuente, Laura
    Vazquez-Sanchez, Sara
    Mercado-Garcia, Elisa
    Rodriguez-Sanchez, Elena
    Garcia-Consuegra, Ines
    Sanz, Ana Belen
    Segura, Julian
    Fernandez-Velasco, Maria
    Liano, Fernando
    Ruilope, Luis M.
    Ruiz-Hurtado, Gema
    [J]. JOURNAL OF PATHOLOGY, 2023, 261 (04): : 427 - 441
  • [27] Role of TWEAK and Fn14 in tumor biology
    Winkles, Jeffrey A.
    Tran, Nhan L.
    Brown, Sharron A. N.
    Stains, Nichole
    Cunliffe, Heather E.
    Berens, Michael E.
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 2761 - 2771
  • [28] IDENTIFICATION OF AURINTRICARBOXYLIC ACID (ATA) AS AN INHIBITOR OF TWEAK-Fn14 SIGNALING IN GLIOBLASTOMA CELLS
    Dhruv, Harshil
    Mathews, Ian
    Chow, Donald
    Yin, Holly
    Berens, Michael
    Tran, Nhan
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [29] Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice
    Meijboom, Katharina E.
    Sutton, Emma R.
    McCallion, Eve
    McFall, Emily
    Anthony, Daniel
    Edwards, Benjamin
    Kubinski, Sabrina
    Tapken, Ines
    Buenermann, Ines
    Hazell, Gareth
    Ahlskog, Nina
    Claus, Peter
    Davies, Kay E.
    Kothary, Rashmi
    Wood, Matthew J. A.
    Bowerman, Melissa
    [J]. SKELETAL MUSCLE, 2022, 12 (01)
  • [30] Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice
    Katharina E. Meijboom
    Emma R. Sutton
    Eve McCallion
    Emily McFall
    Daniel Anthony
    Benjamin Edwards
    Sabrina Kubinski
    Ines Tapken
    Ines Bünermann
    Gareth Hazell
    Nina Ahlskog
    Peter Claus
    Kay E. Davies
    Rashmi Kothary
    Matthew J. A. Wood
    Melissa Bowerman
    [J]. Skeletal Muscle, 12
12345